Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.

Zaman S, Hajiran A, Coba GA, Robinson T, Madanayake TW, Segarra DT, Chobrutskiy BI, Boyle TA, Zhou JM, Kim Y, Mulé JJ, Teer JK, Manley BJ.

Eur Urol Focus. 2019 Dec 31. pii: S2405-4569(19)30379-7. doi: 10.1016/j.euf.2019.12.001. [Epub ahead of print]

PMID:
31901438
2.

Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.

Boyle TA, Khalil FK, Mino-Kenudson M, Sica GL, Moreira AL, Sholl LM, Knight MZ, Zhang L, Saller J, Varella-Garcia M, Berry LD, Chen H, Ellison KE, Rivard CJ, Kugler K, Wistuba II, Fujimoto J, Kwiatkowski DJ, Bunn PA, Kris MG, Haura EB, Hirsch FR; Lung Cancer Mutation Consortium (LCMC) Pathologist Panel Group.

Appl Immunohistochem Mol Morphol. 2019 Nov 22. doi: 10.1097/PAI.0000000000000810. [Epub ahead of print]

PMID:
31876606
3.

A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.

Boyle TA, Quinn GP, Schabath MB, Muñoz-Antonia T, Saller JJ, Duarte LF, Hair LS, Teer JK, Chiang DY, Leary R, Wong CC, Savchenko A, Singh AP, Charette L, Mendell K, Gorgun G, Antonia SJ, Chiappori AA, Creelan BC, Gray JE, Haura EB.

Cancer Med. 2020 Jan;9(1):225-237. doi: 10.1002/cam4.2670. Epub 2019 Nov 20.

4.

Effect of Prior Sternotomy on Outcomes in Transvenous Lead Extraction.

Tsang DC, Perez AA, Boyle TA, Carrillo RG.

Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007278. doi: 10.1161/CIRCEP.119.007278. Epub 2019 Sep 16.

PMID:
31522531
5.

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.

Gray JE, Saltos A, Tanvetyanon T, Haura EB, Creelan B, Antonia SJ, Shafique M, Zheng H, Dai W, Saller JJ, Chen Z, Tchekmedyian N, Goas K, Thapa R, Boyle TA, Chen DT, Beg AA.

Clin Cancer Res. 2019 Nov 15;25(22):6623-6632. doi: 10.1158/1078-0432.CCR-19-1305. Epub 2019 Aug 13.

PMID:
31409616
6.

Proteogenomic landscape of squamous cell lung cancer.

Stewart PA, Welsh EA, Slebos RJC, Fang B, Izumi V, Chambers M, Zhang G, Cen L, Pettersson F, Zhang Y, Chen Z, Cheng CH, Thapa R, Thompson Z, Fellows KM, Francis JM, Saller JJ, Mesa T, Zhang C, Yoder S, DeNicola GM, Beg AA, Boyle TA, Teer JK, Ann Chen Y, Koomen JM, Eschrich SA, Haura EB.

Nat Commun. 2019 Aug 8;10(1):3578. doi: 10.1038/s41467-019-11452-x.

7.

Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis.

Nichols D, Boyle TA, Noyes D, Latifi K, Feygelman V, Jackson I, Vujaskovic Z, Antonia S, Perez BA.

J Thorac Dis. 2018 Nov;10(11):6254-6260. doi: 10.21037/jtd.2018.10.01. No abstract available.

8.

Quality-related events reported by community pharmacies in Nova Scotia over a 7-year period: a descriptive analysis.

Boucher A, Ho C, MacKinnon N, Boyle TA, Bishop A, Gonzalez P, Hartt C, Barker JR.

CMAJ Open. 2018 Dec 18;6(4):E651-E656. doi: 10.9778/cmajo.20180090. Print 2018 Oct-Dec.

9.

Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.

Pérez-Morales J, Mejías-Morales D, Rivera-Rivera S, González-Flores J, González-Loperena M, Cordero-Báez FY, Pedreira-García WM, Chardón-Colón C, Cabán-Rivera J, Cress WD, Gordian ER, Muñoz-Antonia T, Cabrera-Ríos M, Isidro A, Coppola D, Rosa M, Boyle TA, Izumi V, Koomen JM, Santiago-Cardona PG.

PLoS One. 2018 Nov 19;13(11):e0207483. doi: 10.1371/journal.pone.0207483. eCollection 2018.

10.

Transverse testicular ectopia discovered following reduction of an inguinal hernia.

Boyle TA, Perez EA, Diez R, Sola JE, Sanz EE, Garcia A, Fuentes EJ.

J Pediatr Surg. 2019 Mar;54(3):608-611. doi: 10.1016/j.jpedsurg.2018.10.052. Epub 2018 Oct 22.

PMID:
30409476
11.

Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib.

Ng TL, Yu H, Smith DE, Boyle TA, York ER, Leedy S, Gao D, Aisner DL, Van Bokhoven A, Heasley LE, Hirsch FR, Camidge DR.

Clin Lung Cancer. 2019 Jan;20(1):e39-e51. doi: 10.1016/j.cllc.2018.09.001. Epub 2018 Sep 7.

12.

Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion.

Farago AF, Taylor MS, Doebele RC, Zhu VW, Kummar S, Spira AI, Boyle TA, Haura EB, Arcila ME, Benayed R, Aisner DL, Horick NK, Lennerz JK, Le LP, Iafrate AJ, Ou SI, Shaw AT, Mino-Kenudson M, Drilon A.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00037. Epub 2018 Jul 23.

13.

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.

Gray JE, Chiappori A, Williams CC, Tanvetyanon T, Haura EB, Creelan BC, Kim J, Boyle TA, Pinder-Schenck M, Khalil F, Altiok S, Devane R, Noyes D, Mediavilla-Varela M, Smilee R, Hopewell EL, Kelley L, Antonia SJ.

Cancer Immunol Immunother. 2018 Dec;67(12):1853-1862. doi: 10.1007/s00262-018-2236-7. Epub 2018 Sep 12.

14.

Analysis of water sports injuries admitted to a pediatric trauma center: a 13 year experience.

Boyle TA, Rao KA, Horkan DB, Bandeian ML, Sola JE, Karcutskie CA, Allen C, Perez EA, Lineen EB, Hogan AR, Neville HL.

Pediatr Surg Int. 2018 Nov;34(11):1189-1193. doi: 10.1007/s00383-018-4336-z. Epub 2018 Aug 13.

PMID:
30105495
15.

The Price of Imperfection: Complications and Costs Associated With Transvenous Pacemaker Implantation.

Carrillo R, Boyle TA.

JACC Clin Electrophysiol. 2017 Nov;3(11):1306-1307. doi: 10.1016/j.jacep.2017.09.181. Epub 2017 Nov 20. No abstract available.

16.

Impact of Abandoned Leads on Cardiovascular Implantable Electronic Device Infections: A Propensity Matched Analysis of MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

Boyle TA, Uslan DZ, Prutkin JM, Greenspon AJ, Baddour LM, Danik SB, Tolosana JM, Le K, Miro JM, Peacock JE, Sohail MR, Vikram HR, Carrillo RG; MEDIC Investigators.

JACC Clin Electrophysiol. 2018 Feb;4(2):201-208. doi: 10.1016/j.jacep.2017.09.178. Epub 2017 Nov 15.

17.

Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.

Quinn GP, Pentz RD, Muñoz-Antonia T, Boyle TA, Schabath MB, Pratt CL, Shaffer A, Duarte LF, Bowman-Curci M, Antonia SJ, Chiappori AA, Creelan BC, Gray JE, Williams CC, Haura EB.

Patient Educ Couns. 2018 Apr;101(4):703-710. doi: 10.1016/j.pec.2017.11.014. Epub 2017 Nov 28.

18.

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

Kuenzi BM, Remsing Rix LL, Stewart PA, Fang B, Kinose F, Bryant AT, Boyle TA, Koomen JM, Haura EB, Rix U.

Nat Chem Biol. 2017 Dec;13(12):1222-1231. doi: 10.1038/nchembio.2489. Epub 2017 Oct 9.

19.

MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.

Smith MA, Licata T, Lakhani A, Garcia MV, Schildhaus HU, Vuaroqueaux V, Halmos B, Borczuk AC, Chen YA, Creelan BC, Boyle TA, Haura EB.

Clin Cancer Res. 2017 Nov 15;23(22):7084-7096. doi: 10.1158/1078-0432.CCR-16-3006. Epub 2017 Aug 29.

20.

Compliant endovascular balloon reduces the lethality of superior vena cava tears during transvenous lead extractions.

Azarrafiy R, Tsang DC, Boyle TA, Wilkoff BL, Carrillo RG.

Heart Rhythm. 2017 Sep;14(9):1400-1404. doi: 10.1016/j.hrthm.2017.05.005. Epub 2017 May 13.

PMID:
28506914
21.

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft.

Boyle TA, Cohen J, Carrillo R.

HeartRhythm Case Rep. 2016 May 30;2(5):412-414. doi: 10.1016/j.hrcr.2016.05.006. eCollection 2016 Sep. No abstract available.

22.

Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database.

Boyle TA, Uslan DZ, Prutkin JM, Greenspon AJ, Baddour LM, Danik SB, Tolosana JM, Le K, Miro JM, Peacock J, Sohail MR, Vikram HR, Carrillo RG.

Circ Arrhythm Electrophysiol. 2017 Mar;10(3). pii: e004822. doi: 10.1161/CIRCEP.116.004822.

PMID:
28292753
23.

Clinical implications of genetic heterogeneity in multifocal pulmonary adenocarcinomas.

Tanvetyanon T, Boyle TA.

J Thorac Dis. 2016 Dec;8(12):E1734-E1738. doi: 10.21037/jtd.2016.12.06.

24.

Balloon-assisted rescue of four consecutive patients with vascular lacerations inflicted during lead extraction.

Boyle TA, Wilkoff BL, Pace J, Saleem M, Jones S, Carrillo R.

Heart Rhythm. 2017 May;14(5):757-760. doi: 10.1016/j.hrthm.2016.12.028. Epub 2016 Dec 15. No abstract available.

PMID:
27989686
25.

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.

Yu H, Batenchuk C, Badzio A, Boyle TA, Czapiewski P, Chan DC, Lu X, Gao D, Ellison K, Kowalewski AA, Rivard CJ, Dziadziuszko R, Zhou C, Hussein M, Richards D, Wilks S, Monte M, Edenfield W, Goldschmidt J, Page R, Ulrich B, Waterhouse D, Close S, Jassem J, Kulig K, Hirsch FR.

J Thorac Oncol. 2017 Jan;12(1):110-120. doi: 10.1016/j.jtho.2016.09.002. Epub 2016 Sep 14.

26.

PD-L1 Expression in Lung Cancer.

Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR.

J Thorac Oncol. 2016 Jul;11(7):964-75. doi: 10.1016/j.jtho.2016.04.014. Epub 2016 Apr 23. Review. Erratum in: J Thorac Oncol. 2017 Jan;12 (1):157-159.

27.

Pharmacist work stress and learning from quality related events.

Boyle TA, Bishop A, Morrison B, Murphy A, Barker J, Ashcroft DM, Phipps D, Mahaffey T, MacKinnon NJ.

Res Social Adm Pharm. 2016 Sep-Oct;12(5):772-83. doi: 10.1016/j.sapharm.2015.10.003. Epub 2015 Oct 24.

28.

Public perceptions of pharmacist expanded scope of practice services in Nova Scotia.

Bishop AC, Boyle TA, Morrison B, Barker JR, Zwicker B, Mahaffey T, Murphy A.

Can Pharm J (Ott). 2015 Sep;148(5):274-83. doi: 10.1177/1715163515596757.

29.

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.

Zhang L, Yu H, Badzio A, Boyle TA, Schildhaus HU, Lu X, Dziadziuszko R, Jassem J, Varella-Garcia M, Heasley LE, Kowalewski AA, Ellison K, Chen G, Zhou C, Hirsch FR.

J Thorac Oncol. 2015 Jul;10(7):1083-90. doi: 10.1097/JTO.0000000000000562.

30.

ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer.

Boyle TA, Masago K, Ellison KE, Yatabe Y, Hirsch FR.

Clin Lung Cancer. 2015 Mar;16(2):106-11. doi: 10.1016/j.cllc.2014.10.003. Epub 2014 Oct 24.

31.

Using the Health Belief Model to explain patient involvement in patient safety.

Bishop AC, Baker GR, Boyle TA, MacKinnon NJ.

Health Expect. 2015 Dec;18(6):3019-33. doi: 10.1111/hex.12286. Epub 2014 Oct 10.

32.

The Role of Safety Culture in Influencing Provider Perceptions of Patient Safety.

Bishop AC, Boyle TA.

J Patient Saf. 2016 Dec;12(4):204-209.

PMID:
24618647
33.

Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012.

Boyle TA, Bridge JA, Sabatini LM, Nowak JA, Vasalos P, Jennings LJ, Halling KC; College of American Pathologists Molecular Oncology Committee.

Arch Pathol Lab Med. 2014 Mar;138(3):363-70. doi: 10.5858/arpa.2013-0159-CP.

PMID:
24576032
34.

Uptake of Quality-Related Event Standards of Practice by Community Pharmacies.

Boyle TA, Bishop AC, Overmars C, MacMaster K, Mahaffey T, Zwicker B, MacKinnon NJ.

J Pharm Pract. 2015 Oct;28(5):442-9. doi: 10.1177/0897190014522066. Epub 2014 Feb 14.

PMID:
24532822
35.

Regulatory authority approaches to deploying quality improvement standards to community pharmacies: insights from the SafetyNET-RX program.

Boyle TA, Bishop AC, Hillier C, Mahaffey T, MacKinnon NJ, Zwicker B.

J Pharm Pract. 2014 Apr;27(2):138-49. doi: 10.1177/0897190013508138. Epub 2013 Oct 22.

PMID:
24150487
36.

Reflections on the role of the pharmacy regulatory authority in enhancing quality related event reporting in community pharmacies.

Boyle TA, Bishop AC, Mahaffey T, Mackinnon NJ, Ashcroft DM, Zwicker B, Reid C.

Res Social Adm Pharm. 2014 Mar-Apr;10(2):387-97. doi: 10.1016/j.sapharm.2013.06.002. Epub 2013 Jul 2.

37.

Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.

Boyle TA, Bishop AC, Duggan K, Reid C, Mahaffey T, MacKinnon NJ, Mahaffey A.

Res Social Adm Pharm. 2014 Jan-Feb;10(1):45-57. doi: 10.1016/j.sapharm.2013.01.006. Epub 2013 Mar 23.

PMID:
23528447
38.

Head office commitment to quality-related event reporting in community pharmacy.

Scobie AC, Boyle TA, Mackinnon NJ, Mahaffey T.

Can Pharm J (Ott). 2012 May;145(3):e1-6. doi: 10.3821/145.3.cpje1.

39.

Safety implications of standardized continuous quality improvement programs in community pharmacy.

Boyle TA, Ho C, Mackinnon NJ, Mahaffey T, Taylor JM.

J Pharm Pract. 2013 Jun;26(3):228-36. doi: 10.1177/0897190012452312. Epub 2012 Jul 25.

PMID:
22842505
40.

Quality-related event learning in community pharmacies: manual versus computerized reporting processes.

Boyle TA, Scobie AC, MacKinnon NJ, Mahaffey T.

J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):498-506, 2 p following 506. doi: 10.1331/JAPhA.2012.11004.

PMID:
22825230
41.

Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.

Boyle TA, MacKinnon NJ, Mahaffey T, Duggan K, Dow N.

Res Social Adm Pharm. 2012 Nov-Dec;8(6):499-508. doi: 10.1016/j.sapharm.2012.01.005. Epub 2012 Mar 14.

PMID:
22421196
42.

Congruence as a measurement of extended haplotype structure across the genome.

Baschal EE, Jasinski JM, Boyle TA, Fain PR, Eisenbarth GS, Siebert JC.

J Transl Med. 2012 Feb 27;10:32. doi: 10.1186/1479-5876-10-32.

43.

Implications of process characteristics on quality-related event reporting in community pharmacy.

Boyle TA, Scobie AC, MacKinnon NJ, Mahaffey T.

Res Social Adm Pharm. 2012 Jan-Feb;8(1):76-86. doi: 10.1016/j.sapharm.2010.11.004. Epub 2011 Dec 9.

PMID:
22169174
44.

Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis.

Aherne CM, Collins CB, Masterson JC, Tizzano M, Boyle TA, Westrich JA, Parnes JA, Furuta GT, Rivera-Nieves J, Eltzschig HK.

Gut. 2012 May;61(5):695-705. doi: 10.1136/gutjnl-2011-300012. Epub 2011 Aug 3.

45.

Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.

Baschal EE, Sarkar SA, Boyle TA, Siebert JC, Jasinski JM, Grabek KR, Armstrong TK, Babu SR, Fain PR, Steck AK, Rewers MJ, Eisenbarth GS.

J Diabetes. 2011 Sep;3(3):238-47. doi: 10.1111/j.1753-0407.2011.00131.x.

46.

Determinants of medication incident reporting, recovery, and learning in community pharmacies: a conceptual model.

Boyle TA, Mahaffey T, Mackinnon NJ, Deal H, Hallstrom LK, Morgan H.

Res Social Adm Pharm. 2011 Mar;7(1):93-107. doi: 10.1016/j.sapharm.2009.12.001. Epub 2010 Feb 11.

PMID:
21397884
47.

Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.

Symonds JM, Ohm AM, Carter CJ, Heasley LE, Boyle TA, Franklin WA, Reyland ME.

Cancer Res. 2011 Mar 15;71(6):2087-97. doi: 10.1158/0008-5472.CAN-10-1511. Epub 2011 Feb 18.

48.

Parental mosaic trisomy 21 detected following maternal cell contamination of an amniotic fluid specimen from a normal male pregnancy.

Street ML, Barber JC, Boyle TA, Ellis KH, Bullman H, Homfray T.

Prenat Diagn. 2007 Sep;27(9):858-60.

PMID:
17554802
49.

Transmitted duplication of 12q21.32-12q22 includes 48 genes and has no apparent phenotypic consequences.

Barber JC, Maloney VK, Kirchhoff M, Thomas NS, Boyle TA, Castle B.

Am J Med Genet A. 2007 Mar 15;143A(6):615-8. No abstract available.

PMID:
17318843

Supplemental Content

Loading ...
Support Center